In this article, we review the treatment options for the pediatric epileptic encephalopathies and provide an update on the new and emerging therapies targeted at the underlying pathophysiology of many of these syndromes. We illustrate how the identification of the specific genetic and autoimmune causes has made possible the evaluation and development of novel, better targeted therapies, as and at times, avoidance of potentially offending agents.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.spen.2016.06.001 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!